Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — August 2022

Genmab — August 2022

Planlagt Fastgjort Låst Flyttet Genmab
1.1k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • J Offline
    J Offline
    JKY_VH
    wrote on sidst redigeret af
    #951

    Tak bibob:-)

    1 Reply Last reply
    0
    • BulderB Offline
      BulderB Offline
      Bulder
      wrote on sidst redigeret af
      #952

      Blenrep har stærke data og er godkendt i både eu og us i 5. Linje. Men der er dette her øjen-problem…

      1 Reply Last reply
      0
      • BulderB Offline
        BulderB Offline
        Bulder
        wrote on sidst redigeret af
        #953

        Link Preview Image
        See Boxed Warning | Side Effects | BLENREP (belantamab mafodotin-blmf)

        Review side effects for BLENREP (belantamab mafodotin-blmf), which is only available through the REMS program. See PI including Boxed Warning and Medication Guide for patients. For US residents only.

        favicon

        (www.blenrep.com)

        1 Reply Last reply
        0
        • B Offline
          B Offline
          bibob
          wrote on sidst redigeret af
          #954

          TRIMM - 3 https://clinicaltrials.gov/ct2/show/NCT05338775?term=Trimm+2&draw=2&rank=2

          1 Reply Last reply
          0
          • B Offline
            B Offline
            bibob
            wrote on sidst redigeret af
            #955

            Troede kun der var et TRIMM -2. ??

            1 Reply Last reply
            0
            • S Offline
              S Offline
              Sukkeralf
              wrote on sidst redigeret af
              #956

              Spændende at man igen forsøge sig med checkpoint inhibitorer i MM

              1 Reply Last reply
              0
              • D Offline
                D Offline
                deleted-user
                wrote on sidst redigeret af
                #957

                God eftermiddag. Selvom Genmab og JNJ ligger og slås en smule i den dumme voldgift, så fornemmer man, at samarbejdet de kommende mange år vil definere MM markedet med Dara, Tec, Tal og måske super-dara i spil

                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #958

                  Mon PD-1 inhibitoren er Cetrelimab? https://www.jnj.com/janssen-presents-results-from-phase-1b-2-norse-study-in-patients-with-metastatic-or-locally-advanced-urothelial-carcinoma-treated-with-balversa-erdafitinib-in-combination-with-cetrelimab-a-pd-1-inhibitor

                  1 Reply Last reply
                  0
                  • Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktør
                    wrote on sidst redigeret af
                    #959

                    Lidt flere spørgsmål til Q&A er mere end velkommen. 🙂

                    1 Reply Last reply
                    0
                    • B Offline
                      B Offline
                      bibob
                      wrote on sidst redigeret af
                      #960

                      Bulder 14.17. Det ville nok være nærliggende at tro. Da det er et in House drug.

                      1 Reply Last reply
                      0
                      • Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktør
                        wrote on sidst redigeret af
                        #961

                        Godmorgen. 🙂

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          ProinvestorNEWS
                          wrote on sidst redigeret af
                          #962

                          Godmorgen. 🙂

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            ProinvestorNEWS
                            wrote on sidst redigeret af
                            #963

                            Asian Markets Tumble Amid Global Sell-off https://www.proinvestor.com/investornyt/872173/asian-markets-tumble-amid-global-sell-off

                            1 Reply Last reply
                            0
                            • S Offline
                              S Offline
                              Stroka
                              wrote on sidst redigeret af
                              #964

                              God morgen. 🙂

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                ProinvestorNEWS
                                wrote on sidst redigeret af
                                #965

                                Asien: Udsigt til strammere pengepolitik i USA og EU sender aktier ned https://www.proinvestor.com/investornyt/872177/asien-udsigt-til-strammere-pengepolitik-i-usa-og-eu-sender-aktier-ned

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  ProinvestorNEWS
                                  wrote on sidst redigeret af
                                  #966

                                  Aktier efter Jackson Hole: Intet nyt var skidt nyt https://www.proinvestor.com/boards/105698

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    ProinvestorNEWS
                                    wrote on sidst redigeret af
                                    #967

                                    Aktier/åbning: Rød dyne over C25 efter Powell-tale
                                    https://www.proinvestor.com/investornyt/872209/aktier-abning-rod-dyne-over-c25-efter-powell-tale

                                    1 Reply Last reply
                                    0
                                    • B Offline
                                      B Offline
                                      BSinvest
                                      wrote on sidst redigeret af
                                      #968

                                      Hej Helge, Er der der plads til flere spørgsmål til Q&A?

                                      1 Reply Last reply
                                      0
                                      • D Offline
                                        D Offline
                                        deleted-user
                                        wrote on sidst redigeret af
                                        #969

                                        Der skulle være åbent for spg indtil kl. 12.... jo før jo bedre, så Helge ikke får stress 🙂

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #970

                                          GEN1053 starts recruiting https://www.clinicaltrials.gov/ct2/history/NCT05435339?A=2&B=3&C=merged#StudyPageTop

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper